Delayed-release Formulations

Delayed-Release Formulations is a type of modified-release dosage form designed to release the active pharmaceutical ingredient at a predetermined time after administration, distinguished by a deliberate lag phase that postpones drug release until reaching a specific site or condition in the gastrointestinal tract.

216

Publications

7.2K

Citations

944

Authors

356

Institutions

Publications per year

2017–2026

39

Variants

Delayed-release Dosage Forms

Authors

944

  1. TU
    Tomás Undabeytia López

    Instituto de Recursos Naturales y Agrobiología de Sevilla, Spain

    5 publications · 150 citations

    5

    h-index

  2. TG
    Tatiana G. Volova

    Institute of Biophysics, Russia

    5 publications · 185 citations

    5

    h-index

  3. SA
    Stuart Atkinson

    Takeda (United States), United States

    5 publications · 212 citations

    5

    h-index

  4. AV
    Andrew V. Schally

    Tulane University, United States

    5 publications · 208 citations

    5

    h-index

  5. NO
    Natalia O. Zhila

    Institute of Biophysics, Russia

    4 publications · 136 citations

    4

    h-index

1–5 of 944

Venues

  1. PubMed

    Repository · 19 publications · 370 citations

    15

    h-index

  2. Journal of Controlled Release

    9 publications · 519 citations

    9

    h-index

  3. International Journal of Pharmaceutics

    9 publications · 498 citations

    9

    h-index

  4. Drug Development and Industrial Pharmacy

    8 publications · 279 citations

    8

    h-index

  5. Journal of Pharmaceutical Sciences

    5 publications · 136 citations

    5

    h-index

1–5